يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Zh. V. Khailova"', وقت الاستعلام: 0.76s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Кардиоваскулярная терапия и профилактика, Vol 21, Iss 4 (2022)

    وصف الملف: electronic resource

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المساهمون: Funding This study required no funding

    المصدر: Siberian journal of oncology; Том 22, № 5 (2023); 14-27 ; Сибирский онкологический журнал; Том 22, № 5 (2023); 14-27 ; 2312-3168 ; 1814-4861

    وصف الملف: application/pdf

    العلاقة: https://www.siboncoj.ru/jour/article/view/2753/1154Test; Состояние онкологической помощи населению России в 2021 г. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М., 2022. 239 с.; Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1): 7–33. doi:10.3322/caac.21708.; Заридзе Д.Г., Каприн А.Д., Стилиди И.С. Динамика заболеваемости злокачественными новообразованиями и смертности от них в России. Вопросы онкологии. 2018; 64(5): 78–91. doi:10.37469/0507-3758-2018-64-5-578-591.; Eloranta S., Smedby K.E., Dickman P.W., Andersson T.M. Cancer survival statistics for patients and healthcare professionals – a tutorial of real-world data analysis. J Intern Med 2021; 289(1): 12–28. doi:10.1111/joim.13139.; Shulman L.N., Palis B.E., McCabe R., Mallin K., Loomis A., Winchester D., McKellar D. Survival As a Quality Metric of Cancer Care: Use of the National Cancer Data Base to Assess Hospital Performance. J Oncol Pract 2018; 14: 59–72. doi:10.1200/JOP.2016.020446.; Mariotto A.B., Noone A.M., Howlader N., Cho H., Keel G.E., Garshell J., Woloshin S., Schwartz L.M. Cancer survival: an overview of measures, uses, and interpretation. J Natl Cancer Inst Monogr 2014; (49): 145–86. doi:10.1093/jncimonographs/lgu024.; Hessel F. Burden of DiseaseBurdenof disease(s). In: Kirch W, editor. Encycl. Public Heal., Dordrecht: Springer Netherlands; 2008, p. 94–6. doi:10.1007/978-1-4020-5614-7_297.; Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy. Seattle, WA: IHME, 2013.; Vos T., Lim S.S., Abbafati C., Abbas, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396:1204–22. doi:10.1016/S0140-6736(20)30925-9.; Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2019; 5(12): 1749–68. doi:10.1001/jamaoncol.2019.2996.; Global Burden of Disease 2019 Cancer Collaboration. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022; 8(3): 420–44. doi:10.1001/jamaoncol.2021.6987.; Rai M., Goyal R. Chapter 33 – Pharmacoeconomics in Healthcare. Pharm. Med. Transl. Clin. Res., Boston: Academic Press. 2018; p. 465–72. doi:10.1016/B978-0-12-802103-3.00034-1.; Stevens G.A., Alkema L., Black R.E., Boerma J.T., Collins G.S., Ezzati M., Grove J.T., Hogan D.R., Hogan M.C., Horton R., Lawn J.E., Marušić Ana, Mathers C.D., Murray C.J.L., Rudan I., Salomon J.A., Simpson P.J., Vos T., Welch V. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet (London, England) 2016; 388: 19–23. doi:10.1016/S0140-6736(16)30388-9.; The institute for health metrics and evaluation [Internet] [cited 2023 Mar 3]. URL: https://www.healthdata.orgTest/.; Tai S.Y., Cheon S., Yamaoka Y., Chien Y.W., Lu T.H. Changes in the rankings of leading causes of death in Japan, Korea, and Taiwan from 1998 to 2018: a comparison of three ranking lists. BMC Public Health 2022; 22: 926. doi:10.1186/s12889-022-13278-7.; Defossez G., Uhry Z., Delafosse P., Dantony E., d’Almeida T., Plouvier S., Bossard N., Bouvier A.M., Molinié F., Woronoff A.S., Colonna M., Grosclaude P., Remontet L., Monnereau A., the French Network of Cancer Registries (FRANCIM). Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing. BMC Cancer 2021; 21: 726. doi:10.1186/s12885-021-08261-1.; Quante A.S., Ming C., Rottmann M., Engel J., Boeck S., Heinemann V., Westphalen C.B., Strauch K. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030. Cancer Med 2016; 5(9): 2649–56. doi:10.1002/cam4.767.; Sadovnikova N., Lebedinskaya O., Bezrukov A., Davletshina L. Cross-country comparisons and differentiation of countries by key indicators of the socio-demographic situation. Academy of Strategic Management Journal. 2021; 20(6): 1-11.; WHO methods and data sources for global burden of disease estimates 2000–2019 [Internet]. Department of Data and Analytics Division of Data, Analytics and Delivery for Impact WHO, Geneva, 2020 [cited 2023 Mar 3]. URL: https://cdn.who.int/media/docs/default-source/ghodocuments/global-health-estimates/ghe2019_daly-methods.pdfTest.; Shkolnikov V.M., Andreev E.M., Zhang Z., Oeppen J., Vaupel J.W. Losses of expected lifetime in the United States and other developed countries: methods and empirical analyses. Demography 2011; 48: 211–39. doi:10.1007/s13524-011-0015-6.; Кусакина В.О., Омельяновский В.В., Пустовалов Д.Н. Подход к оценке потерянных лет ожидаемой продолжительности жизни для реализации программ развития здравоохранения. Медицинские технологии. Оценка и выбор. 2021; (4): 28–35. doi:10.17116/medtech20214304128.; Федеральная служба государственной статистики (Росстат) [Internet]. [cited 2023 Mar 3]. URL: https://www.fedstat.ru/indicator/43219Test.; Российская база данных по рождаемости и смертности [Internet]. Центр демографических исследований Российской экономической школы. [cited 2023 Mar 3]. URL: http://demogr.nes.ru/index.php/ru/demogr_indicat/dataTest.; Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71(3): 209–49. doi:10.3322/caac.21660.; Mattiuzzi C., Lippi G. Current Cancer Epidemiology. J Epidemiol Glob Health 2019; 9(4): 217–22. doi:10.2991/jegh.k.191008.001.; Bray F., Jemal A., Grey N., Ferlay J., Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13(8): 790–801. doi:10.1016/S1470-2045(12)70211-5.; Vineis P., Wild C.P. Global cancer patterns: causes and prevention. Lancet (London, England) 2014; 383: 549–57. doi:10.1016/S0140-6736(13)62224-2.; World Health Organization [Internet]. Global Action Plan: For the Prevention and Control of Non-communicable Diseases. (2013–2020). [cited 2023 Mar 3]. URL: https://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdfTest.; Abrams H.R., Durbin S., Huang C.X., Johnson S.F., Nayak R.K., Zahner G.J., Peppercorn J. Financial toxicity in cancer care: origins, impact, and solutions. Transl Behav Med 2021; 11(11): 2043–54. doi:10.1093/tbm/ibab091.; Hofmarcher T., Lindgren P., Wilking N., Jönsson B. The cost of cancer in Europe 2018. Eur J Cancer 2020; 129: 41–9. doi:10.1016/j.ejca.2020.01.011.; American Cancer Society Cancer Action Network [Internet]. The Costs of Cancer. 2020 [cited 2023 Mar 3]. URL: https://www.fightcancer.org/sites/default/files/National%20Documents/Costs-of-Cancer-202010222020.pdfTest.; Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М., 2022. 252 с.; ФГБУ «Центр экспертизы и контроля качества медицинской помощи» Минздрава России [Internet]. [cited 2023 Mar 3]. URL: http://ly.corpTest. rosmedex.ru/.; Nagai H., Kim Y.H. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis 2017; 9(3): 448–51. doi:10.21037/jtd.2017.02.75.; Жуйкова Л.Д., Ананина О.А., Сиротина А.С., Пикалова Л.В., Фокин В.А., Кононова Г.А. Оценка потерянных лет жизни (DALY) и экономический ущерб от преждевременной смерти по причине злокачественных новообразований шейки матки, тела матки и яичников населения Томской области. Современная онкология. 2022; 24(4): 494–8. doi:10.26442/18151434.2022.4.201709.; Gourbin C., Wunsch G. Health, Illness, and Death. Demography: Analysis and Synthesis. Burlington: Academic Press. 2006; 2: 5–12.; https://www.siboncoj.ru/jour/article/view/2753Test

  6. 6
  7. 7
  8. 8

    المصدر: Cardiovascular Therapy and Prevention. 21:3235

    مصطلحات موضوعية: Cardiology and Cardiovascular Medicine, Education

  9. 9